Drug Trial Radar · NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,200
Planned (sponsor's estimate)
Start
Mar 14, 2016
Primary completion
Dec 31, 2027
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- American Society of Clinical OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- AstraZeneca; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; Genentech, Inc.; Pfizer; Taiho Oncology, Inc.; Novartis; Merck Institute for Therapeutic Research; Boehringer Ingelheim; Seattle Genetics (now a wholly owned subsidiary of Pfizer)
- First posted
- Feb 26, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Conditions
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Advanced Solid Tumors
Interventions
Sunitinib (CLOSED TO ENROLLMENT)Drug
drug
Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT)Drug
drug
Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT)Drug
drug
Olaparib (CLOSED TO ENROLLMENT)Drug
drug
Nivolumab and Ipilimumab (CLOSED TO ENROLLMENT)Drug
drug
Abemaciclib (CLOSED TO ENROLLMENT)Drug
drug
Talazoparib (CLOSED TO ENROLLMENT)Drug
drug
Atezolizumab and Talazoparib (CLOSED TO ENROLLMENT)Drug
drug
Tucatinib plus Trastuzumab Subcutaneous (SC) (CLOSED TO ENROLLMENT)Drug
drug
FutibatinibDrug
drug
Dabrafenib plus TrametinibDrug
Drug
Fam-Trastuzumab Deruxtecan-Nxki (TDxD)Drug
Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate defined as % of participants in a cohort with complete or partial response or with stable disease according to standard response criteriaTime frame: Assessed at 16 weeks of treatment
Locations
181 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama · Recruiting
Cancer Treatment Centers of America-Phoenix
Phoenix, Arizona · Recruiting
Sutter Auburn
Auburn, California · Recruiting
Sutter Alta Bates
Berkeley, California · Recruiting
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
Los Angeles, California · Recruiting
Kaiser Permanente - Oakland Medical Center
Oakland, California · Recruiting
Sutter Palo Alto Medical Foundation: Palo Alto
Palo Alto, California · Recruiting
Kaiser Permanente - Roseville Medical Center
Roseville, California · Recruiting
Sutter Roseville
Roseville, California · Recruiting
Kaiser Permanente - Sacramento Medical Center
Sacramento, California · Recruiting
Sutter Sacramento
Sacramento, California · Recruiting
Kaiser Permanente - South San Francisco Medical Center
San Francisco, California · Recruiting
California Pacific Medical Center Research Institute
San Francisco, California · Recruiting
Kaiser Permanente - San Francisco Medical Center
San Francisco, California · Recruiting
Sutter Cancer Research Consortium
San Francisco, California · Recruiting
Kaiser Permanente - San Jose Medical Center
San Jose, California · Recruiting
Kaiser Permanente - San Leandro Medical Center
San Leandro, California · Recruiting
Sutter Sansum Clinic
Santa Barbara, California · Recruiting
Kaiser Permanente - Santa Clara Medical Center
Santa Clara, California · Recruiting
Sutter Palo Alto Medical Foundation: Santa Cruz
Santa Cruz, California · Recruiting
Sutter Palo Alto Medical Foundation: Fremont
Santa Cruz, California · Recruiting
Sutter Palo Alto Medical Foundation: Sunnyvale
Sunnyvale, California · Recruiting
Kaiser Permanente - Vallejo Medical Center
Vallejo, California · Recruiting
Kaiser Permanente - Walnut Creek Medical Center
Walnut Creek, California · Recruiting
Saint Vincent's Medical Center (SVMC)
Bridgeport, Connecticut · Recruiting
Hartford Hospital
Hartford, Connecticut · Recruiting
Midstate Medical Center (MSMC)
Meriden, Connecticut · Recruiting
The Hospital of Central Connecticut (HOCC) Cancer Center
New Britain, Connecticut · Recruiting
William W. Backus Hospital
Norwich, Connecticut · Recruiting
Charlotte Hungerford
Torrington, Connecticut · Recruiting
Windham Hospital (WH)
Willimantic, Connecticut · Recruiting
Florida Cancer Specialists North / Sarah Cannon Research Institute
Altamonte Springs, Florida · Active not recruiting
University of Miami/Sylvester Cancer Institute - Aventura
Aventura, Florida · Recruiting
Florida Cancer Specialists South / Sarah Cannon Research Institute
Bonita Springs, Florida · Active not recruiting
Florida Cancer Specialists South / Sarah Cannon Research Institute
Bradenton, Florida · Active not recruiting
Florida Cancer Specialists North / Sarah Cannon Research Institute
Brandon, Florida · Active not recruiting
Florida Cancer Specialists South / Sarah Cannon Research Institute
Cape Coral, Florida · Active not recruiting
Florida Cancer Specialists North / Sarah Cannon Research Institute
Clearwater, Florida · Active not recruiting
University of Miami/Sylvester Cancer Institute - Lennar
Coral Gables, Florida · Recruiting
University of Miami/Sylvester Cancer Institute - Deerfield Beach
Deerfield Beach, Florida · Recruiting
Showing 40 of 181 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.